FDA Can't Publish Unsupported Concerns About Pharmacy

By Cassie M. Chew · January 17, 2024, 11:00 PM EST

In a sealed order, a Connecticut federal judge has granted a compounding pharmacy's request to block the U.S. Food and Drug Administration from publishing insights it made during a site visit...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

SCA Pharmaceuticals, LLC v. U.S. Food and Drug Administration et al

Case Number

3:23-cv-01462

Court

Connecticut

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

November 06, 2023

Recent Articles By Cassie

February 15, 2024
House Committee Blasts VA, Oracle For E-Record Failures
February 14, 2024
Settlements of 3 Drug Cos. Get Prelim OK In Price-Fixing MDL
February 12, 2024
FDA Seeks Comment On Guidance For Clinical Trial Sponsors
February 11, 2024
Rise In Billing For Catheters May Signal $2B Medicare Fraud
February 07, 2024
Existing Laws May Stymie AI Potential To Improve Healthcare
February 06, 2024
Proposed Rules in NY Target Anti-Competitive PBM Practices
February 05, 2024
Proposed Class Action Settlement May Cost Acella $46.5M
February 01, 2024
DOJ Looking For Privacy Perils In Digital Healthcare
January 31, 2024
FDA Has More Cyber Guidance Planned For Device Makers
January 29, 2024
HHS Urges Court To Reject Novo Nordisk Drug Plan Challenge